Useful in situations where identity or class of the drug or drugs of interest is not known. Not recommended for assessment in routine compliance and/or abuse contexts.
Qualitative Immunoassay/Gas Chromatography-Mass Spectrometry/Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Fresh random urine.
Transport 25 mL urine. (Min: 12 mL)
Ambient: 5 days; Refrigerated: 2 weeks; Frozen: 2 months
The following drugs or drug classes may be detected:
Acetaminophen, barbiturates, benzodiazepines, carbamazepine, carisoprodol, chlorpheniramine, cocaine and metabolites, diphenhydramine, ethchlorvynol, ibuprofen, lidocaine, meprobamate, narcotics and synthetics, phencyclidine, phenothiazines, phenytoin, primidone and metabolites, pyrilamine, salicylate, sympathomimetic amines, theophylline, tricyclic and other antidepressants.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
This test is not optimized for most drugs of abuse (amphet/methamphet, barbiturates, benzodiazepines, cocaine, methadone, opiates, propoxyphene, PCP, THC); instead refer to Drug Panel 9, Urine - Screen with Reflex to Confirmation/Quantitation (ARUP test code 0092186), Drug Panel 7, Urine - Screen with Reflex to Confirmation/Quantitation (ARUP test code 0092184).
|Component Test Code*||Component Chart Name||LOINC|
|0090500||Drug Screen (Nonforensic), Urine, Qual||12286-1|
- Carisoprodol Screen with Reflex Confirmation
- Drug Analysis
- Multiple Drug Analysis
- Tox Screen Urine
- Urine Drug Screen